A detailed history of River Road Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, River Road Asset Management, LLC holds 48,451 shares of AMGN stock, worth $13.7 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
48,451
Previous 50,575 4.2%
Holding current value
$13.7 Million
Previous $15.8 Million 1.21%
% of portfolio
0.22%
Previous 0.23%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$309.38 - $337.38 $657,123 - $716,595
-2,124 Reduced 4.2%
48,451 $15.6 Million
Q2 2024

Jul 19, 2024

SELL
$262.75 - $319.31 $615,360 - $747,824
-2,342 Reduced 4.43%
50,575 $15.8 Million
Q1 2024

Apr 26, 2024

SELL
$268.87 - $324.56 $3.84 Million - $4.64 Million
-14,281 Reduced 21.25%
52,917 $15 Million
Q4 2023

Jan 31, 2024

SELL
$255.7 - $288.46 $422,927 - $477,112
-1,654 Reduced 2.4%
67,198 $19.4 Million
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $547,718 - $680,007
-2,505 Reduced 3.51%
68,852 $18.5 Million
Q2 2023

Jul 20, 2023

SELL
$214.27 - $253.37 $920,932 - $1.09 Million
-4,298 Reduced 5.68%
71,357 $15.8 Million
Q1 2023

Apr 27, 2023

BUY
$225.79 - $275.2 $676,015 - $823,948
2,994 Added 4.12%
75,655 $18.3 Million
Q4 2022

Feb 01, 2023

SELL
$229.03 - $291.01 $368,051 - $467,653
-1,607 Reduced 2.16%
72,661 $19.1 Million
Q3 2022

Nov 04, 2022

SELL
$224.46 - $253.15 $30,302 - $34,175
-135 Reduced 0.18%
74,268 $16.7 Million
Q2 2022

Jul 20, 2022

SELL
$230.71 - $256.74 $299,000 - $332,735
-1,296 Reduced 1.71%
74,403 $18.1 Million
Q1 2022

May 12, 2022

SELL
$219.27 - $242.57 $2.15 Million - $2.38 Million
-9,804 Reduced 11.47%
75,699 $18.3 Million
Q4 2021

Feb 01, 2022

SELL
$198.88 - $227.6 $2.19 Million - $2.51 Million
-11,013 Reduced 11.41%
85,503 $19.2 Million
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $1.54 Million - $1.8 Million
-7,234 Reduced 6.97%
96,516 $20.5 Million
Q2 2021

Aug 10, 2021

SELL
$233.58 - $259.14 $3.29 Million - $3.65 Million
-14,100 Reduced 11.96%
103,750 $25.3 Million
Q1 2021

May 12, 2021

SELL
$221.91 - $258.6 $2.11 Million - $2.45 Million
-9,486 Reduced 7.45%
117,850 $29.3 Million
Q4 2020

Feb 10, 2021

SELL
$216.38 - $257.67 $8.35 Million - $9.95 Million
-38,596 Reduced 23.26%
127,336 $29.3 Million
Q3 2020

Nov 09, 2020

SELL
$234.65 - $260.95 $2.51 Million - $2.8 Million
-10,715 Reduced 6.07%
165,932 $42.2 Million
Q2 2020

Aug 12, 2020

SELL
$197.81 - $242.74 $4.63 Million - $5.68 Million
-23,392 Reduced 11.69%
176,647 $41.7 Million
Q1 2020

May 14, 2020

SELL
$182.24 - $241.7 $1.43 Million - $1.89 Million
-7,832 Reduced 3.77%
200,039 $40.6 Million
Q4 2019

Feb 12, 2020

SELL
$189.21 - $243.2 $9.97 Million - $12.8 Million
-52,717 Reduced 20.23%
207,871 $50.1 Million
Q3 2019

Nov 05, 2019

SELL
$174.11 - $208.62 $4.28 Million - $5.12 Million
-24,565 Reduced 8.61%
260,588 $50.4 Million
Q2 2019

Aug 12, 2019

BUY
$166.7 - $195.41 $5.36 Million - $6.28 Million
32,127 Added 12.7%
285,153 $52.5 Million
Q1 2019

May 02, 2019

SELL
$180.87 - $203.88 $1.6 Million - $1.81 Million
-8,862 Reduced 3.38%
253,026 $48.1 Million
Q4 2018

Feb 06, 2019

SELL
$178.4 - $208.25 $3.66 Million - $4.27 Million
-20,508 Reduced 7.26%
261,888 $51 Million
Q3 2018

Nov 01, 2018

SELL
$185.29 - $208.89 $5.21 Million - $5.88 Million
-28,138 Reduced 9.06%
282,396 $58.5 Million
Q2 2018

Jul 25, 2018

SELL
$166.05 - $186.51 $4.77 Million - $5.36 Million
-28,740 Reduced 8.47%
310,534 $57.3 Million
Q1 2018

May 04, 2018

SELL
$169.43 - $198.0 $4.31 Million - $5.03 Million
-25,427 Reduced 6.97%
339,274 $57.8 Million
Q4 2017

Feb 06, 2018

SELL
$168.79 - $188.59 $1.29 Million - $1.44 Million
-7,659 Reduced 2.06%
364,701 $63.4 Million
Q3 2017

Nov 03, 2017

SELL
$167.29 - $191.0 $1.35 Million - $1.54 Million
-8,084 Reduced 2.12%
372,360 $69.4 Million
Q2 2017

Aug 08, 2017

BUY
N/A
380,444
380,444 $65.5 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $152B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track River Road Asset Management, LLC Portfolio

Follow River Road Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of River Road Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on River Road Asset Management, LLC with notifications on news.